- Home
- Life Sciences
- Anaesthesia & Respiratory Devices
Anaesthesia Respiratory Devices Market Research Report – Segmented By Region (North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2019 to 2030.
-
Published date -30th Jan 2024
-
Formats -PDF, CSV
-
Region -Global
Anticoccidial Drugs Market Size (2021 to 2030)
The global anticoccidial drugs market is expected to have a growth rate of 3.61% CAGR from 2021 to 2030. As a result, the market is anticipated to grow by USD 1691.94 Million by 2028.
Impact of COVID-19 on the Anticoccidial Drugs Market
The disease has spread to almost every country globally since the COVID-19 virus outbreak in December 2019, prompting the World Health Organization to declare it a public health emergency. Coccidiosis is a viral disease caused by a single-cell parasite that can only be seen under a microscope. It affects the intestinal tracts of animals. Weight loss, moderate sporadic to extreme diarrhea, diarrhea containing blood or mucus, dehydration, and decreased breeding are all signs of coccidiosis, one of the most common parasitic diseases in domesticated animals.
Anticoccidial Drugs Market Dynamics
Anticoccidial drugs are a part of the veterinary medicine industry. These drugs are used to prevent and treat coccidiosis in animals. When animals are diagnosed with coccidiosis, they suffer from diarrhea, weight loss, and reduced growth and productivity. Coccidiosis can also result in death in some cases. Coccidiosis majorly impacts the intestines of animals. This parasitic disease is infectious. To treat coccidiosis, anticoccidial drugs are used in the treatment procedures to remove the parasites.
Segments and Related Analysis
Based on the Drug type, the ionophore anticoccidials segment had the largest market share of the global anticoccidial drugs market in 2022. Based on animal type, the poultry animal segment had the largest market share of the global anticoccidial drugs market in 2022.
By Region Analysis
Regionally, the North American anticoccidial drugs market was the most dominating region globally in 2021 and was worth USD 393.18 million in 2022. The adoption of advanced manufacturing drug techniques majorly drives this regional market. In addition, launching innovative medicines that favor producing the most top-quality products significantly influences the global anticoccidial drugs market.
Key Market Players and Competitive Landscape
Noteworthy companies in the global anticoccidial drugs market include Bayer Health care, Zoetis, Elanco, Merial, Merck Animal Healthcare, Ceva Santé Animale, Virbac, Boehringer Ingelheim Animal Health, Novartis Animal Healthcare, and Smartvet Inc.
Recent Happenings in the Anticoccidial Drugs Market
In April 2022, Amlan International, a U.S.-based company operating in veterinary healthcare, announced natural alternatives to anticoccidial drugs. In May 2020, Zoetis showed suckling calves with significant weight gain from implants. It is a considerable increase in weaning weight.
